Central Laboratories Applications & Studies

1. Cutting Red Tape: Direct Data Capture In Clinical Trials 4/12/2024

   Say goodbye to duplicate work in clinical trials. Discover how Direct Data Capture revolutionizes research, benefiting patients, sponsors, and sites while streamlining processes.

2. Patient Caregiver Network Improves Post-Seizure Trial Data 3/26/2024

   Discover how a pharmaceutical CRO addressed concerns about seizure diary timing in a rare disease study, leveraging insights from Medable's Patient Community Network to optimize data collection.

3. Rare Disease Prioritization Model And Landscape Analysis 3/15/2024

   Uncover how a global pharmaceutical company seeking to identify promising indications among rare diseases to develop preclinical candidate molecules received an in-depth disease analysis to guide its strategic decision-making.

4. How Vanguard Clinical Harnesses CDMS/EDC For Faster Results 2/6/2024

   Uncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.

5. Showcasing Advances In CAR-T Research At The 65th ASH Annual Meeting 1/18/2024

   Take a look at three research posters presented at the 65th American Society of Hematology (ASH) annual meeting, emphasizing the impact of academic-industry collaborations on CAR-T therapy.

6. Unified Platform Supports Rapid Implementation Of Rescue Study 1/17/2024

   Explore how these integrated solutions helped an emerging biopharma to implement a plan for study build and migration with minimal disruption to sites.

7. eSource For A COVID Treatment Trial 1/17/2024

   Unearth how this emerging biopharmaceutical company was able to overcome challenges to successfully facilitate a Phase 2 trial for a COVID-19 treatment in critically ill patients.

8. Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial 1/16/2024

   Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.

9. Discngine Advances Life Sciences Research More Securely With OCI 12/6/2023

   Unearth how this integrated data management on Oracle Cloud Infrastructure (OCI) enabled an R&D firm to build cloud native and low-code apps faster and more efficiently.

10. COA Adaptations: Is Machine Translation A Viable Option? 12/4/2023

    Take a moment to compare human translation (HT) and machine translation (MT) specifically within the back translation phase for both Clinical Outcome Assessments and supplementary study materials.